Systems and methods for automating rna expression calls in a cancer prediction pipeline
AssigneeTempus Labs, Inc.
InventorsJoshua SK Bell, Catherine Igartua, Joshua Drews
Life of this patent
Estimating the term…
Loading patent…
AssigneeTempus Labs, Inc.
InventorsJoshua SK Bell, Catherine Igartua, Joshua Drews
Estimating the term…
Systems and methods are provided for performing quality control analysis. The method obtains, in electronic form, a batch dataset comprising, for each respective sample in a batch of samples, a corresponding plurality of sequence reads derived from the respective sample by targeted or whole transcriptome RNA sequencing and corresponding metadata for the respective sample. The method determines for the batch dataset a cohort-matched reference batch, where the cohort-matched reference batch is balanced for tissue site, tumor purity, cancer type, sequencer identity, or date sequenced. The method performs one or more global batch quality control tests on the batch dataset using at least the cohort-matched reference batch. The method removes respective samples from the batch dataset that fail any one of the one or more global batch quality control tests or flagging for manual inspection respective samples that fail any one of the one or more global batch quality control tests.
1-25. (canceled)
A method of performing quality control, the method comprising:
(canceled)
A method of validating a change in an RNA expression pipeline, the method comprising:
(canceled)
(canceled)
A method of adding RNA expression data to a reference database comprising a plurality of reference database samples, the method comprising:
(canceled)
(canceled)
47-56. (canceled)
Dependencies are inferred from the claim text.